Skip to main content

Elias Zerhouni, Raynard Kington

Premium
National Institutes of Health Director Elias Zerhouni said last week that he will resign from his position at the end of October "to pursue writing projects and explore other professional opportunities."

Zerhouni said that his departure is timed to synchronize with the end of the current White House administration and that he does not consider the move to be a resignation.

Raynard Kington, deputy director of NIH, is expected to serve as acting director until a new White House names his successor.

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.